Analysis of multidrug resistant group B streptococci with reduced penicillin susceptibility forming small, less hemolytic colonies
Open Access
- 17 August 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (8) , e0183453
Abstract
Group B streptococci (GBS; Streptococcus agalactiae) are the leading cause of neonatal invasive diseases and are also important pathogens for elderly adults. Until now, nearly all GBS with reduced penicillin susceptibility (PRGBS) have shown β-hemolytic activity and grow on sheep blood agar. However, we have previously reported three PRGBS clinical isolates harboring a CylK deletion that form small less hemolytic colonies. In this study, we examined the causes of small, less hemolytic colony formation in these clinical isolates. Isogenic strains were sequenced to identify the mutation related to a small colony size. We identified a 276_277insG nucleic acid insertion in the thiamin pyrophosphokinase (tpk) gene, resulting in premature termination at amino acid 103 in TPK, as a candidate mutation responsible for small colony formation. The recombinant strain Δtpk, which harbored the 276_277insG insertion in the tpk gene, showed small colony formation. The recombinant strain ΔcylK, which harbored the G379T substitution in cylK, showed a reduction in hemolytic activity. The phenotypes of both recombinant strains were complemented by the expression of intact TPK or CylK, respectively. Moreover, the use of Rapid ID 32 API and VITEK MS to identify strains as GBS was evaluated clinical isolates and recombinant strains. VITEK MS, but not Rapid ID 32 API, was able to accurately identify the strains as GBS. In conclusion, we determined that mutations in tpk and cylK caused small colonies and reduced hemolytic activity, respectively, and characterized the clinical isolates in detail.Keywords
Funding Information
- the Ministry of Health, Labour and Welfare of Japan (H24-Shinkou-Ippan-010)
- Japan Agency for Medical Research and Development (the Research Program on Emerging/Re-emerging Infectious Disease Project)
This publication has 36 references indexed in Scilit:
- Incidence, Etiology, and Outcome of Bacterial Meningitis in Infants Aged <90 Days in the United Kingdom and Republic of Ireland: Prospective, Enhanced, National Population-Based SurveillanceClinical Infectious Diseases, 2014
- Emerging Trends in the Epidemiology of Invasive Group B Streptococcal Disease in England and Wales, 1991–2010Clinical Infectious Diseases, 2013
- Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxoneJournal of Antimicrobial Chemotherapy, 2009
- Capsular Type and Antibiotic Resistance in Streptococcus agalactiae Isolates from Patients, Ranging from Newborns to the Elderly, with Invasive InfectionsAntimicrobial Agents and Chemotherapy, 2009
- Genetic Heterogeneity in pbp Genes among Clinically Isolated Group B Streptococci with Reduced Penicillin SusceptibilityAntimicrobial Agents and Chemotherapy, 2008
- Point Mutation in the Group B Streptococcal pbp2x Gene Conferring Decreased Susceptibility to β-Lactam AntibioticsAntimicrobial Agents and Chemotherapy, 2008
- First Molecular Characterization of Group B Streptococci with Reduced Penicillin SusceptibilityAntimicrobial Agents and Chemotherapy, 2008
- Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005JAMA, 2008
- Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.2002
- Group B streptococcusThe Lancet, 1999